DJS Law Group said investors who bought PROCEPT BioRobotics Corporation shares during the February 28, 2024 to February 25, 2026 class period can contact the firm about a securities class action and possible lead plaintiff appointments, with a September 22, 2026 deadline. The case alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC (U.S. securities regulator) Rule 10b-5. The complaint claims Procept inflated revenue by using aggressive discounting to pull sales forward from future periods, a practice that allegedly created excess inventory in the market and made the company’s public statements materially false and misleading throughout the class period. The firm said investors do not need to be appointed lead plaintiff to share in any potential recovery.